Joel L. Cohen;Girish S. Munavalli;Michael H. Gold;Tze-Chiang Meng
发明人:
Michael H. Gold,Joel L. Cohen,Girish S. Munavalli,Tze-Chiang Meng
申请号：
US13619983
公开号：
US09492682B2
申请日:
2012.09.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This disclosure is directed to the use of sequentially applied topical therapy with a lower dosage strength imiquimod composition and photodynamic therapy for treating actinic keratosis, wherein the photodynamic therapy is administered subsequent to the topical therapy with the imiquimod composition. In some embodiments, the imiquimod composition comprises from about 1% (w/w) to about 4.25% (w/w) imiquimod.
